Postgraduate Teaching (PGT) 

October 8 – 9, 2022

The PGT Programme occurs during UEG Week with two days of excellent Continuing Medical Education 

Access online programme

(All times are CEST)

Keep on track with your training

PGT is a dynamic, live, two-day, in-person educational experience! It focuses on the relevance for the clinical day-to-day business and provides profound updates on the latest developments in GI and hepatology topics.

Join lively experiences containing interactive audience voting, tricky clinical cases, controversial debates, real-time faculty engagement, and exciting cases. 

The 3-year curriculum has returned and will follow the curriculum for year 2 in 2022.

PGT programme: October 8 (09:00) – October 9 (11:30)

Target group
  • Field of practice: Gastroenterologists in training and in practice; GI physicians and general practitioners with an interest in GI & hepatology topics
  • Career level: Fellows in training, established doctors (except top experts, specialists, researchers)
  • No age restriction
PGT recordings

Recordings of past PGT presentations are available online in the UEG Library.

Access recent PGT recordings collection

Learning Objectives

3-year Curriculum

The PGT follows a 3-year curriculum, which is based on recommendations of the ESBGH Curriculum – The Blue Book. Delegates can start the curriculum at any year of the cycle and will receive a certificate once they have completed all three years. 2022 is year 2 of the curriculum!

Search the PGT Curriculum and its learning objectives per topic:
Colorectal, Endoscopy and imaging, IBD, Liver, Oesophagus, Nutrition, Pancreas and biliary tract, Small bowelStomach and Therapy update

  • Year 2: Colorectal (2022 / 2025)
  • Year 3: Colorectal (2023 / 2026)
  • Year 1: Colorectal (2021 / 2024)
Year 2: Colorectal (2022 / 2025)

Chronic diarrhoea
•    Differential diagnosis of chronic diarrhoea, including microscopic colitis, malabsorption, bile acid diarrhoea, etc.
•    Different tools for the diagnostic work-up
•    Therapeutic management

Colorectal cancer: Staging, surgery and adjuvant therapies
•    Staging and the multidisciplinary team meeting (including guidelines)
•    Evidence-based surgical management with curative intent, inclunding ERAS, etc.
•    Surgery for colorectal liver metastases
•    Neoadjuvant and adjuvant therapies for colon and rectal cancer

Colorectal polyps
•    Classification and endoscopic characterisation
•    Management and surveillance for sporadic polyps
•    Familial syndromes: Presentation and management

•    Diagnosis of IBS: What is the optimal work-up?
•    Medical treatment options, including pharmacological management, for IBS according to the clinical presentation (IBS-C, IBS-D)
•    Dietary management of IBS
•    Psychosocial management
•    IBS overlap syndromes

Lower GI bleeding
•    Clinical assessment, investigation and therapy for acute lower GI bleeding
•    Diagnosis and management of small and large bowel ischaemia

Year 3: Colorectal (2023 / 2026)

Advanced colorectal cancer
•    Role of chemotherapy in metastatic colon and rectal cancer
•    Other aspects of palliation: Pain management, nutrition, etc.
•    Management of recurrence of colorectal cancer
•    Management of  high risk and elderly colorectal cancer patients

•    Diagnostic work-up of constipated patients depending on age and symptoms
•    Role of diet, physical activity, fluid intake etc.
•    Medical therapy
•    Biofeedback and other behavioural treatment alternatives
•    Indications for surgery, including sacral nerve stimulation

Diverticular disease
•    Pathogenesis of diverticular disease
•    Management of symptomatic disease
•    Management of acute diverticulitis
•    Role of imaging and endoscopy in diverticular disease management
•    Indications for surgery and surgical options

•    Identification and management of common proctological problems, including haemorrhoids, fissures and pruritus ani
•    Investigation and management of anal fistula, including imaging and surgical management
•    Defaecatory and continence disorders and the pelvic floor

Year 1: Colorectal (2021 / 2024)

Faecal incontinence
•    Pathophysiology and differential diagnosis of faecal incontinence
•    Manometric classification of anorectal disorders
•    Current tests of anorectal motor and sensory function
•    Therapeutic management: Conservative, pharmacological, behavioural and surgical modalities

Infectious colitis
•    Evaluation, differential diagnosis and management of patients with acute diarrhoea
•    Clostridium difficile: First-line management and recurrent infections
•    Faecal transplantation: Indications and modalities

Management of abdominal emergencies
•    Overview of potential causes of the acute abdomen (non-surgical and surgical)
•    Clinical assessment, laboratory and imaging diagnostic tools
•    Initial therapeutic management of the acute abdomen
•    Novel areas of development and innovations

Management of colorectal polyps and early colorectal cancer 
•    Screening strategies according to risk stratification
•    Endoscopic detection, characterisation and reporting
•    Therapeutic management: From endoscopy to surgery

  • Year 2: Endoscopy and imaging (2022 / 2025)
  • Year 3: Endoscopy and imaging (2023 / 2026)
  • Year 1: Endoscopy and imaging (2021 / 2024)
Year 2: Endoscopy and imaging (2022 / 2025)

Advanced therapeutic endoscopic techniques
•    Difficult papilla and altered anatomy: Alternative approaches to ERCP
•    ERCP for difficult stones including cholangioscopy
•    Overview on EUS-guided therapeutic procedures

Video Case Sessions

Upper GI bleeding and endoscopic therapy of endoscopic and surgical complications
•    Overall and endoscopic management of patients with variceal bleeding
•    Overall and endoscopic management of patients with non-variceal bleeding
•    Haemostatic techniques in variceal and non-variceal bleeding
•    Endoscopic management of endoscopic complications (perforations) and surgical complications 

Endoscopic handling of colorectal polyps and treatment of pancreatic collections
•    Characterisation and resection techniques of colorectal polyps
•    EUS-guided drainage for pseudocysts and walled-off necrosis
•    Endoscopic necrosectomy techniques

Year 3: Endoscopy and imaging (2023 / 2026)

Quality in endoscopic practice
•    Understanding the importance of establishing quality measurements in endoscopy
•    Overview of the different quality measurements in oesophago-gastroduodenoscopy (OGD) and colonoscopy
•    How to set up a safe and efficient endoscopic service
•    Insights in safety issues regarding sterilisation and radioprotection

Video Case Sessions

Biliary cannulation, spincterotomy/precut and stone disease and ERCP in altered anatomy
•    Biliary cannulation: Papillary and ductal anatomy, cannulation techniques, including device, guidewire/contrast use, double guidewire
•    Biliary sphincterotomy and precut: Techniques and recognition of perforations and complications
•    Biliary stone disease: Diagnosis, standard extraction techniques and advanced techniques
•    ERCP in altered anatomy: Identification of the desired loop and cannulation techniques in patients with altered anatomy

Endoscopic diagnosis and management of Barrett's oesophagus and associated neoplasia, early gastric and duodenal lesions
•    Early gastric lesions and early duodenal lesions: Identification and characterisation, resection techniques and management of complications
•    Barrett's oesophagus and associated neoplasia: Characterisation of Barrett’s and visible lesions, resection techniques (EMR, ESD) and ablation techniques (RFA and Cryo)

Year 1: Endoscopy and imaging (2021 / 2024)

Advanced diagnostic endoscopy
•    Techniques for enhancing endoscopic vision: Chromo-endoscopy, high definition, NBI, FICE and endo-microscopy
•    Intraductal exploration with cholangioscopy
•    Enhancing EUS: Elastography, sonoview and endo-microscopy

Malignant biliary obstruction
•    Differential diagnosis of biliary strictures: Clinical assessment, laboratory tests, imaging techniques and tissue acquisition
•    The role of endoscopy and surgery in the management of malignant biliary strictures

Video Case Sessions

Endoscopic management of pancreatobiliary diseases
•    Endoscopic diagnosis and treatment of hilar and distal biliary strictures, including diagnosis with cholangioscopy and treatment with stenting
•    Endoscopic management of strictures and stones in patients with chronic pancreatitis
•    Endoscopic diagnosis of pancreatic cysts: EUS for the diagnosis of pancreatic cystic lesions, differential diagnosis, tools to enhance diagnosis

Endoscopic treatment of mid and lower gut diseases (excluding polyps)
•    Diagnostic and therapeutic management for lower GI bleeding, including timing and modalities for endoscopic treatment
•    Diagnosis and therapeutic management in small bowel disease, including indications and modalities for deep enteroscopy, as well as management for suspected small bowel bleeding and polyp resection
•    Endoscopic management of patients with IBD: colon cancer surveillance, polyp and stricture management
•    Endoscopic management of GI strictures (oesophageal, duodenal and colon: dilation and stent insertion)

  • Year 2: IBD (2022 / 2025)
  • Year 3: IBD (2023 / 2026)
  • Year 1: IBD (2021 / 2024)
Year 2: IBD (2022 / 2025)

Cancer and IBD
•    Pathophysiology of link between chronic inflammation and carcinogenesis
•    Surveillance schemes in patient with IBD according to risk factors
•    How to manage findings: Surgery and endoscopy

Management of Crohn's disease
•    Medical treatment algorithms
•    Objective measures for treatment and the role of complete mucosal healing
•    Interdisciplinary approach for perianal fistula

Management of ulcerative colitis: The acute patient
•    The hospitalised patient with acute colitis: Differential diagnosis
•    Medical management of ulcerative colitis
•    Surgery: Timing, types, outcome determining factors

Year 3: IBD (2023 / 2026)

How to use drugs in IBD
•    Modalities of therapeutic drug monitoring of biologics
•    Prevention and management of drug-related complications
•    Thiopurines and methotrexate: For whom and how?

Management of ulcerative colitis (UC)
•    Standard therapeutic management of patients with UC
•    The optimal use of 5-ASA therapy
•    Therapy with thiopurines: Is there still a role in UC and for whom?
•    Anti-TNF and anti-integrins and JAK inhibitors: Mechanisms and optimal use in UC and the use of newer pharmacological agents
•    When should surgery be considered in UC?

Monitoring of disease activity in IBD
•    Objective measures of disease activity
•    Ultrasound, MRI capsule endoscopy and endoscopy 
•    Biochemical markers 

Year 1: IBD (2021 / 2024)

Difficult to treat IBD
•    How to define treatment failure and refractory IBD
•    Infectious complications to consider
•    Therapeutic options in patients failing biological agents
•    The role of surgery in refractory cases

Early management of IBD
•    Differential diagnosis of the patient with chronic diarrhoea
•    Diagnostic work-up and use of laboratory tests, imaging and endoscopy.
•    Therapeutic management in early stages

Extraintestinal manifestations of IBD
•    Epidemiology of extra-intestinal manifestations of IBD (PSC, skin, joints)
•    Clinical manifestations and diagnostic strategy
•    Therapeutic considerations with relation to IBD

Therapy update in IBD (in addition for 2020 only)
•    Non-complicated ileal Crohn's disease: biologics or watchful waiting?
•    New options in acute severe ulcerative colitis
•    Perianal Crohn's disease
•    Most promising mechanisms

  • Year 2: Liver (2022 / 2025)
  • Year 3: Liver (2023 / 2026)
  • Year 1: Liver (2021 / 2024)
Year 2: Liver (2022 / 2025)

Hepatocellular carcinoma (HCC)
•    Diagnostic modalities and differential diagnosis
•    Staging and classifications
•    Treatment algorithms and the role of liver transplantation

Liver and pregnancy
•    Overview of specific liver diseases in pregnancy, according to birth term.
•    Other liver diseases diagnosed during pregnancy
•    Management of liver diseases, including when to terminate pregnancy

Metabolic and vascular disorders of the liver
•    Overview of metabolic disorders: Diagnosis and therapy
•    The place of genetic evaluation in diagnostic work up
•    Vascular disorders of the liver: Diagnostic work up
•    Management of vascular disorders: The role of anticoagulation, TIPS and liver transplantation

Year 3: Liver (2023 / 2026)

Alcohol-related liver disease
•    Epidemiology of alcohol-related liver disease
•    Diagnosis and treatment of alcoholic hepatitis
•    Indications for liver transplantation
•    Management of alcohol dependence

Complications of liver cirrhosis
•    Ascites: Diagnostic and therapeutic approach
•    Diagnosis and treatment of hepatic encephalopathy
•    Nutrition and cirrhosis
•    Management of portal hypertension and its complications

Fulminant hepatitis, liver failure and liver transplantation
•    Diagnosis of fulminant liver failure, including differential diagnosis
•    Diagnostic work up for suspected drug induced liver injury (DILI)
•    Non-specific management
•    Transplantation and acute liver failure

Year 1: Liver (2021 / 2024)

Assessment of liver function
•    When to assess liver function
•    What methods are available for liver function assessment
•    How to predict and prevent liver failure prior to major surgery

Diagnostic work-up of a liver nodule
•    Differential diagnosis of liver nodules in the non-cirrhotic and cirrhotic liver
•    Diagnostic management: Imaging modalities and when to obtain tissue
•    Therapeutic management: Surveillance or treatment (except HCC)

•    Epidemiological concerns regarding NAFLD/NASH
•    How to differentiate from alcohol-related liver disease?
•    Relationship with the metabolic syndrome and cardiovascular diseases
•    Risk stratification
•    Therapeutic management

Viral hepatitis
•    The changing epidemiology of viral hepatitis
•    Diagnostic modalities for viral hepatitis
•    Therapeutic management
•    Long-term complications
•    HCV elimination: strategies, micro-elimination and possible target groups

  • Year 2: Oesophagus (2022 / 2025)
  • Year 3: Oesophagus (2023 / 2026)
  • Year 1: Oesophagus (2021 / 2024)
Year 2: Oesophagus (2022 / 2025)

Barrett’s oesophagus
•    Epidemiology, aetiology and the risk of cancer
•    Diagnosis and classification
•    Surveillance schemes according to risk
•    Chemoprevention
•    Endoscopic management

Non-cardiac chest pain
•    Differential diagnosis of oesophageal chest pain
•    How to investigate, including the use of reflux studies and manometry
•    Pharmacological therapy: PPI and beyond

Year 3: Oesophagus (2023 / 2026)

Oesophageal cancer
•    Overview of diagnosis and staging
•    Management of early oesophageal cancer
•    Review the role of radiotherapy, surgery and chemotherapy

Swallowing disorders: Oropharyngeal dysphagia
•    Causes of oropharyngeal dysphagia, including Zenker diverticulum and cricopharyngeal bar
•    Initial bedside and specialist investigation
•    Diagnostic strategy
•    Treatment of oropharyngeal dysphagia and other symptoms
•    Management of Zenker diverticulum: Endoscopy versus surgery

Year 1: Oesophagus (2021 / 2024)

Benign causes of oesophageal dysphagia
•    Clinical presentation and differential diagnosis of dysphagia
•    Diagnostic modalities for determining diagnosis
•    Therapeutic management of benign oesophageal dysphagia (Eosinophilic oesophagitis, oe-sophageal motility disorders etc.)

Management of gastro-oesophageal reflux disease (GORD)
•    Concepts of GORD pathophysiology and diagnostic classification
•    Appropriate use of different modalities for GORD diagnosis (pH-metry, pH-impedance etc.)
•    Pharmacological therapy
•    Non-pharmacological therapy, including endoscopic procedures and surgery

  • Year 2: Nutrition (2022 / 2025)
  • Year 3: Nutrition (2023 / 2026)
  • Year 1: Nutrition (2021 / 2024)
Year 2: Nutrition (2022 / 2025)

•    Mechanisms of nutrient absorption and pathophysiology of malabsorption
•    Clinical features and differential diagnosis of the underlying diseases
•    Therapeutic management

Nutrition in GI diseases
•    Nutrition in IBD
•    Nutrition and NASH
•    Nutrition in patients with advanced liver disease, including pre- and post-transplantation, with a focus on sarcopenia / frailty
•    Nutrition in patients with gastrointestinal cancer, including perioperative nutrition

Year 3: Nutrition (2023 / 2026)

Anorexia and unexplained weight loss
•    Optimal diagnostic work-up for patients with unexplained weight loss because of reduced appetite and oral intake
•    Differentiating between organic causes and food-intake behavioural problems
•    Therapeutic multimodal management

Complications in nutrition and how to avoid them
•    Prevention and treatment of the refeeding syndrome
•    Complications of enteral access insertion (gastrostomy, jejunostomy, etc.) and enteral nutrition
•    Complications of home parenteral nutrition

Year 1: Nutrition (2021 / 2024)

Diagnosis and treatment of malnutrition
•    Definition and criteria of malnutrition
•    Tools for sarcopenia assessment
•    Identifying which patient is at risk
•    Artificial nutrition (enteral and parenteral): Indications and modalities of administration
•    Ethical considerations regarding artificial nutrition

  • Year 2: Pancreas and biliary tract (2022 / 2025)
  • Year 3: Pancreas and biliary tract (2023 / 2026)
  • Year 1: Pancreas and biliary tract (2021 / 2024)
Year 2: Pancreas and biliary tract (2022 / 2025)

Autoimmune disease of liver and bile ducts
•    Differential diagnosis and therapy of autoimmune liver disease: AIH, PBC, PSC and other cholangiopathies
•    Typical symptoms, histology, sensitivity and specificity of serology of autoimmune liver disease
•    Alternative diagnosis to exclude
•    Natural course of the disease and possible therapeutic interventions

Biliary stones
•    Clinical symptoms and imaging modalities for diagnosis of bile stones
•    Managing symptomatic biliary stones, including gallstones and choledocolithiasis
•    Defining indication and timing of EUS, ERCP and cholecystectomy

•    Diagnosis, classification and staging of cholangiocarcinoma
•    Indications and modalities for surgical resection
•    Indications for pre-operative tissue acquisition and stenting
•    The role of endoscopy and radiology for palliation and their limitations

Cystic pancreatic lesions
•    Differential diagnosis of cystic pancreatic lesions and the role of CT, MRI and EUS
•    Natural history of pancreatic cystic lesions and risk of malignant transformation
•    Management of cystic pancreatic lesions and the indications for surgery

Year 3: Pancreas and biliary tract (2023 / 2026)

Autoimmune pancreatitis
•    Epidemiology, clinical presentation and subtypes of auto-immune pancreatitis
•    Diagnostic work-up and differential diagnosis with pancreatic cancer
•    Current treatment options
•    lgG4 related disease and associated disorders

Chronic pancreatitis
•    Pathophysiological mechanisms
•    Clinical aspects of chronic pancreatitis, including etiological factors, symptoms and compli-cations
•    Therapeutic management strategy: Medical management, endoscopy and surgery

Pancreatic neuroendocrine tumours
•    Clinical spectrum of P-NETs
•    Diagnostic work-up
•    Curative, symptomatic and palliative therapeutic algorithm

Severe acute pancreatitis: Initial management and complications
•    Optimal management of severe acute necrotizing pancreatitis
•    Clinical and imaging aspects of pancreatic collections
•    Indications, timing, therapeutic modalities for drainage (surgical, endoscopic, radiological)

Year 1: Pancreas and biliary tract (2021 / 2024)

Management of acute pancreatitis
•    How to stage severity in acute pancreatitis
•    Determination of aetiology
•    Initial management: Hydration, antibiotics or not, nutrition, ERCP for biliary acute pancreatitis
•    Work-up for recurrent acute pancreatitis

Pancreatic adenocarcinoma
•    Diagnostic work-up and pitfalls of available diagnostic modalities
•    Therapeutic management: chemotherapy and surgery, including management of elderly pa-tients
•    Palliation: The role of endoscopy, nutrition and pain management

  • Year 2: Small bowel (2022 / 2025)
  • Year 3: Small bowel (2023 / 2026)
  • Year 1: Small bowel (2021 / 2024)
Year 2: Small bowel (2022 / 2025)

Small bowel imaging and endoscopy
•    Overview of available modalities for small bowel imaging: capsule endoscopy, radiology studies, MRI, deep enteroscopy techniques
•    Occult blood loss: How to investigate and how to treat
•    Small bowel polyp resection (Peutz Jeghers)

Year 3: Small bowel (2023 / 2026)

Obstruction and ileus
•    Aetiology and investigation of ileus, ischaemia and obstruction
•    Management of ileus
•    Surgical and endoscopic management of acute intestinal obstruction
•    Management of chronic intestinal pseudo-obstruction and other similar disorders
•    Palliation for malignant small and large bowel obstruction

Small bowel tumours
•    Clinical symptoms and diagnostic work-up
•    Overview of differential diagnosis, including neuroendocrine tumours
•    Therapeutic management

Year 1: Small bowel (2021 / 2024)

Chronic intestinal failure
•    Causes of chronic intestinal failure
•    Short and long-term complications of chronic intestinal failure
•    Management of chronic intestinal failure: Total parenteral nutrition and beyond (including transplantation)

Coeliac disease
•    Coeliac disease: Epidemiology, diagnosis and therapeutic management
•    How to differentiate between coeliac disease, eosinophilic gastroenteritis, food allergies, non-coeliac gluten sensitivity and IBS
•    Refractory coeliac disease

  • Year 2: Stomach (2022 / 2025)
  • Year 3: Stomach (2023 / 2026)
  • Year 1: Stomach (2021 / 2024)
Year 2: Stomach (2022 / 2025)

Bariatric surgery
•    Indications and techniques for bariatric surgery and their mechanisms of actions
•    Complications following bariatric surgery and their management
•    Long-term physiological consequences of bariatric surgery and its metabolic complications

Gastric cancer
•    Epidemiology, risk factors and screening requirements
•    Diagnostic modalities for early and advanced cancer, including chromoendoscopy, electronic chromoendoscopy and imaging procedures
•    Therapeutic management: endoscopy and surgery

Year 3: Stomach (2023 / 2026)

Gastric polyps and submucosal lesions
•    Clinical, endoscopic and histopathological features of gastric polyps and submucosal lesions
•    Possible syndromes that might be associated with gastric polyps
•    Therapeutic management

Peptic ulcer disease
•    Epidemiology and incidence of peptic ulcer disease
•    Management of gastric ulcer
•    Investigation of suspected duodenal ulcer
•    H. pylori testing or prompt endoscopy?
•    Complications of peptic ulcer disease
•    Peptic ulcer disease and NSAID’s, including other aetiologies such as ischemia, chemotherapy and polymedication

Year 1: Stomach (2021 / 2024)

Dyspepsia and gastroparesis
•    Definition and differential diagnosis of nausea and vomiting
•    Use of diagnostic tests such as imaging procedures and gastric emptying time
•    Pharmacological and non-pharmacological therapy for gastroparesis
•    Management of functional dyspepsia

H. pylori
•    Epidemiology and consequences of H. pylori infection
•    Available diagnostic modalities and their pitfalls
•    Effects on H. pylori infection on other organs and diseases
•    Eradication schemes and treatment resistance

Upper GI bleeding
•    Clinical assessment, investigation and therapy for acute upper GI bleeding, including special requirements for elderly patients
•    Management of patients on anticoagulant and anti-platelet therapy, both in the acute situation and before scheduled diagnostic or therapeutic endoscopy

  • Year 2: Therapy update (2022)
  • Year 3: Therapy update (2023)
  • Year 1: Therapy update (2024)
Year 2: Therapy update (2022)

Checkpoint inhibitors in GI-disease: Boon and bane 

  • Indications for check-point inhibitors in GI-Cancer
  • Diagnosis and differential diagnosis of Toxicity of Check-point inhibitor therapy
  • Treatment of GI-toxicity of CPI, criteria for treatment discontinuation of CPI due to side effects
Year 3: Therapy update (2023)

The upcoming topic and learning objectives will be determined annually by the UEG Scientific Committee.

Year 1: Therapy update (2024)

The upcoming topic and learning objectives will be determined annually by the UEG Scientific Committee.

Programme & Education Management
Elisabeth Pfeiffer
  • M: +43 699 1997 16 23
  • T: +43 1 997 16 39